Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, experts say that things are looking up for regenerative medicine.
Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, experts say that things are looking up for regenerative medicine.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
Sign up for the Funding Newswire
Follow where the public and private R&I money is going and which collaborative opportunities you can pursue.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
